Shanghai Xuerong Bio-Tech approves all resolutions at AGM

Shanghai Xuerong Bio-Technology held its Annual General Meeting, with 291 shareholders or their representatives attending, representing 23.2536% of the company's total shares. All resolutions were approved, including the 2024 Board and Supervisory Board work reports, the 2024 annual report and summary, approval of the audit report, the 2024 financial statements, the 2024 profit distribution proposal, the re-appointment of the accounting firm, director compensation, the cancellation of certain unvested restricted stock units, the 2025 guarantee limit, and amendments to the company's articles of association. Voting was conducted through a combination of on-site and online methods.国浩 Lawyers issued a legal opinion confirming the legality and validity of the meeting procedures and resolutions.